Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
Alessandro Maria Berton, Nunzia Prencipe, Roberta Giordano, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 4, pp. 873-875
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesús Villar, Carlos Ferrando, Domingo Martínez, et al.
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 3, pp. 267-276
Closed Access | Times Cited: 1016
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
Sobia Noreen, Irsah Maqbool, Asadullah Madni
European Journal of Pharmacology (2021) Vol. 894, pp. 173854-173854
Open Access | Times Cited: 167
SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità)
Giovanni Corona, Elisabetta Baldi, Andrea M. Isidori, et al.
Journal of Endocrinological Investigation (2020) Vol. 43, Iss. 8, pp. 1153-1157
Open Access | Times Cited: 98
COVID-19 and corticosteroids: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1189-1205
Open Access | Times Cited: 62
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel
Mojca Jensterle, Rok Herman, Andrej Janež, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7326-7326
Open Access | Times Cited: 54
The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review
Taïeb Ach, Ben Haj Slama Nassim, Gorchane Asma, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 1, pp. 96-109
Open Access | Times Cited: 8
Altitude and COVID‐19: Friend or foe? A narrative review
Grégoire P. Millet, Tadej Debevec, Franck Brocherie, et al.
Physiological Reports (2020) Vol. 8, Iss. 24
Open Access | Times Cited: 63
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Issues for the management of people with diabetes and COVID-19 in ICU
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 49
Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
Zemene Demelash Kifle, Akeberegn Gorems Ayele, Engidaw Fentahun Enyew
Journal of Environmental and Public Health (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 33
Covid-19, the thyroid and the pituitary — The real state of play
Aurore Geslot, Philippe Chanson, Philippe Caron
Annales d Endocrinologie (2022) Vol. 83, Iss. 2, pp. 103-108
Open Access | Times Cited: 25
ENT Manifestations in Patients Suffering from COVID-19: Study from a COVID Hospital in North India
Anitya Srivastava, Ashish Agarwal, Syed Zeeshan Alam
International Archives of Otorhinolaryngology (2022) Vol. 26, Iss. 01, pp. e148-e151
Open Access | Times Cited: 20
Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)
João Roberto Maciel Martins, Danilo Villagelin, Gisah Amaral de Carvalho, et al.
Archives of Endocrinology and Metabolism (2021)
Open Access | Times Cited: 22
Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)
Frans A. Kuypers, Christina A. Rostad, Evan J. Anderson, et al.
Experimental Biology and Medicine (2021) Vol. 246, Iss. 23, pp. 2543-2552
Open Access | Times Cited: 20
Endocrine and metabolic complications of COVID-19: lessons learned and future prospects
Abdolreza Esmaeilzadeh, Reza Elahi, Amir Siahmansouri, et al.
Journal of Molecular Endocrinology (2022) Vol. 69, Iss. 3, pp. R125-R150
Open Access | Times Cited: 15
Perspectives on glucocorticoid treatment for COVID-19: a systematic review
Leonardo Pessanha Cordeiro, Eduarda O.N.N. Linhares, Fernanda G.O. Nogueira, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 3, pp. 728-735
Open Access | Times Cited: 16
Real-world evidence of the use of glucocorticoids for severe COVID-19
Alejandra Albarrán‐Sánchez, Claudia Ramírez‐Rentería, Moisés Mercado, et al.
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 7
Challenges in hyperglycemia management in critically ill patients with COVID-19
Rajesh Kethireddy, Darshan Gandhi, Asim Kichloo, et al.
World Journal of Critical Care Medicine (2022) Vol. 11, Iss. 4, pp. 219-227
Open Access | Times Cited: 5
PHARMACOTHERAPY of COVID-19
Begüm Yurdakök-Di̇kmen, Yağız Pat, Ergin Dileköz, et al.
Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni (2020) Vol. 11, Iss. 2, pp. 80-114
Open Access | Times Cited: 7
Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China
Haojun Yang, Yunfang Chi, Zhuohui Chen, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 4
The impact of non-invasive respiratory support techniques on the lethal outcome frequency in adult with severe respiratory failure caused by the new coronavirus infection
К. А. Цыганков, I. N. Grаchev, V. I. Shatalov, et al.
Messenger of Anesthesiology and Resuscitation (2021) Vol. 18, Iss. 1, pp. 47-56
Open Access | Times Cited: 4
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
Dario Cattaneo, Luca Pasina, Federico Conti, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 12, pp. 2849-2851
Open Access | Times Cited: 4
Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells
Mehmet Bostancıklıoğlu, Mehri İğci, Mustafa Ulaşlı
Gene (2024) Vol. 911, pp. 148366-148366
Closed Access
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission
Emanuele Varaldo, Francesca Rumbolo, Nunzia Prencipe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2019-2019
Open Access
Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
Snejina Vassileva, Valeria Mateeva, Kossara Drenovska
Clinics in Dermatology (2021) Vol. 39, Iss. 3, pp. 430-445
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top